Inconsistencies in how CRCs with PTPRK-RSPO3 fusions and CRCs with RNF43 mutations enhance their sensitivity to extracellular WNT signaling may be due to different selective pressures during cancer evolution. This evidence concerns the gene PTPRK and cancer.